FAQs

1.What does Gevo do?
2.How is Gevo stock traded?
3.When and where was the Company incorporated?
4.Where is Gevo’s corporate headquarters?
5.How many employees does Gevo have?
6.What is Gevo’s fiscal year?
7.When was the Company's initial public offering? What was the price?
8.Who were the underwriters on Gevo’s IPO?
9.Does Gevo pay dividends?
10.Does Gevo have a dividend reinvestment plan and how can I participate?
11.Who is Gevo's transfer agent?
12.How can I invest in Gevo?
13.Whom do I contact with questions about my stock?
14.How do I transfer stock, change the address on my shareholder account, or replace a lost stock certificate?
15.Does Gevo have a direct stock purchase plan?
16.Who is Gevo's auditor?
17.Who is Gevo's legal counsel?
18.Where can I get the latest corporate news releases and financial reports?
19.How do I obtain copies of annual and quarterly reports and SEC filings?
20.When and where will Gevo hold its next annual meeting?
21.Whom should I contact regarding investor inquiries?
1.What does Gevo do?
 Gevo is a leading renewable chemicals and advanced biofuels company that is developing bio-based alternatives to petroleum-based products using a combination of biotechnology and classical chemistry.

2.How is Gevo stock traded?
  Gevo common stock is traded on the NASDAQ Global Market under the symbol GEVO.

3.When and where was the Company incorporated?
  Gevo was incorporated in the state of Delaware in June 2005 under the name Methanotech, Inc. and filed an amendment to its certificate of incorporation changing its name to Gevo, Inc. in March 2006.

4.Where is Gevo’s corporate headquarters?
 345 Inverness Drive South
Building C, Suite 210
Englewood, CO 80112
Tel: 303-858-8358

5.How many employees does Gevo have?
  As of December 31, 2010, Gevo and its subsidiaries had 91 employees.

6.What is Gevo’s fiscal year?
  Gevo’s fiscal year ends December 31.

7.When was the Company's initial public offering? What was the price?
 On February 8, 2011, Gevo priced 7,150,000 shares at $15.00 per share.

8.Who were the underwriters on Gevo’s IPO?
  The underwriters on Gevo’s IPO were UBS Investment Bank, Piper Jaffray, Citi and Simmons & Company International.

9.Does Gevo pay dividends?
  Gevo does not currently pay dividends and does not expect to do so in the foreseeable future.

10.Does Gevo have a dividend reinvestment plan and how can I participate?
  Gevo does not offer a dividend reinvestment plan.

11.Who is Gevo's transfer agent?
 Gevo’s transfer agent is the American Stock Transfer & Trust Company. You can reach them at:

American Stock Transfer & Trust Company, LLC
6201 15th Avenue
Brooklyn, NY 11219
Tel: 718-921-8217
Fax: 718-236-4588

12.How can I invest in Gevo?
  You may buy stock in Gevo from a registered brokerage firm or stock purchase service provider. You cannot buy stock directly from the company.

13.Whom do I contact with questions about my stock?
 American Stock Transfer & Trust Company, LLC
6201 15th Avenue
Brooklyn, NY 11219
Tel: 718-921-8217
Fax: 718-236-4588

14.How do I transfer stock, change the address on my shareholder account, or replace a lost stock certificate?
  You may contact our transfer agent.

15.Does Gevo have a direct stock purchase plan?
  Gevo does not currently have a direct stock purchase plan.

16.Who is Gevo's auditor?
  Deloitte and Touche LLP

17.Who is Gevo's legal counsel?
  Gevo’s general counsel is Brett Lund. Our external legal counsel is Paul, Hastings, Janofsky & Walker LLP.

18.Where can I get the latest corporate news releases and financial reports?
  Please sign up for email alerts in the Investors section of Gevo’s website.

19.How do I obtain copies of annual and quarterly reports and SEC filings?
  These documents may be obtained on Gevo’s website under the Investors section. SEC filings may also be obtained from the SEC website, www.sec.gov.

20.When and where will Gevo hold its next annual meeting?
  Stockholders will be notified of the date, time and location of the company’s annual meeting in 2011.

21.Whom should I contact regarding investor inquiries?
 

For investor-related inquiries please contact:

Mike Willis
CFO and EVP of Corporate Development & Strategy
(720) 267-8636


Back to Top